Althea sells MNKD 7.23: Orexigen Therapeutics has Relatively Underperformed its Peers in the Biotechnology Industry (OREX, MNKD, IMGN, INSM, INFI)
This is what we found: Orexigen Therapeutics (NASDAQ:OREX) ranks first with a loss of 3.80%; MannKind (NASDAQ:MNKD) ranks second with a loss of 2.70%; and Immunogen (NASDAQ:IMGN) ranks third with a loss of 2.62%. Insmed (NASDAQ:INSM) follows with a loss of ... ...
24 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home